
Friday, April 5, 2013
9:15 am – 12:30 pm
Douglas Mennin, PhD
Department of Psychology
Hunter College, CUNY
Co-chair
Jordan Smoller, MD, ScD
Department of Psychiatry
Harvard Medical School
Center for Human Genetic Research
Massachusetts General Hospital
Co-chair
The Scientific Research Symposium will address three mechanisms of intervention for mood and anxiety disorders:
Despite advances in psychosocial and pharmacological interventions for anxiety and mood disorders, a considerable subgroup of remains of refractory patients, or those who do not improve or who worsen to baseline levels over the long term. Further, it has been unclear what the essential elements of successful therapies are and for whom they work best.
In the past few years an exciting surge of research has been translating basic findings of genetic, neurobiological, physiological, and behavioral analysis to improve our understanding of various psychopathological conditions. Consistent with this translational emphasis, the National Institute of Mental Health (NIMH) has articulated two important facets of its strategic plan.
As a result of these trends and initiatives, interest has increased in honing treatments to target underlying mechanisms more directly. Three areas that have shown promising advances are in extinction learning, direct neurobiological modulation, and mechanism-targeted nonpharmacological interventions.
Mohammed R. Milad, MD
Department of Psychiatry
Massachusetts General Hospital and
Harvard Medical School
Kerry Ressler, MD, PhD
Yerkes National Primate Research Center
Emory University
Ronald S. Duman, PhD
Abraham Ribicoff Research Facilities
Department of Psychiatry
Yale University
Carlos A. Zarate, Jr., MD
Experimental Therapeutics and Pathophysiology Branch
Division of Intramural Research Programs
National Institute of Mental Health
Jutta Joormann, PhD
Department of Psychology
University of Miami
Greg J. Siegle, PhD
Department of Psychiatry
University of Pittsburgh School of Medicine